Dennis Gillings, CBE, Continues as Chairman, Board of Directors

23/04/2012 — RESEARCH TRIANGLE PARK, N.C. — (BUSINESS WIRE)

Quintiles, the world’s leading global biopharmaceutical services
company, today announced the appointment of Tom Pike as chief executive
officer. This appointment is part of the company’s long-term succession
planning. Dennis Gillings, CBE, who founded the company, continues as
executive chairman of its Board of Directors. Pike joins Quintiles on
April 30, 2012.

“Tom has an impressive track record of helping customers navigate
fast-changing environments and solving complex business issues,”
Gillings said. “He has experience with organizations our size and much
larger that will be extremely valuable to us. Tom has a disciplined and
forthright approach that will enable him to earn the trust of customers
and employees alike. I’m confident he will soon make his mark on our
company and the industry at large, continuing the Quintiles tradition of
entrepreneurial leadership and pioneering growth.”

Pike brings 30 years of experience to Quintiles, spanning a variety of
industries and leading companies. He spent 22 years at Accenture,
including more than 10 years in leadership roles. At Accenture, Pike’s
roles included leading the North America Health and Products business
areas. Prior to that, he was the global chief operating officer for
Accenture’s Resources operating group and had also served as the
company’s chief strategy officer. Since leaving Accenture in 2010, Pike
has been involved with a number of start-ups in the technology and
healthcare sectors.

Pike said: “Healthcare is the most important industry of the next
quarter century, and I’m excited because Quintiles is right at the
center of improving the health of millions of people around the world.
It’s extremely motivating to join the company at this point in time. I
understand the magnitude and complexity of its customers’ challenges.
I’m looking forward to bringing my skills and experience to help this
talented team build on its successes as it continues its journey as one
of the world’s great companies.”

About Quintiles

Quintiles is the only fully integrated biopharmaceutical services
company offering clinical,
commercial,
consulting
and capital
solutions worldwide. Our network of more than 25,000 professionals in 60
countries has an eye on the future while delivering results today with
an unwavering commitment to patients, safety and ethics. Quintiles helps
biopharmaceutical companies develop and commercialize products to
improve and lengthen patients’ lives while demonstrating value to
stakeholders. Visit www.quintiles.com
for more information and www.quintiles.com/news
for additional company news.

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50248240&lang=en

Click here to subscribe to Mobile Alerts for Quintiles.

http://alerts.businesswire.com/subscribe/quintiles

CONTACT:

Quintiles
Phil Bridges, Media Relations
+1-919-998-1653
mobile:
+1-919-457-6347
phil.bridges@quintiles.com
or
Greg
Connors, Investor Relations
+1-919-998-2000
invest@quintiles.com

KEYWORDS: United States North America North Carolina

INDUSTRY KEYWORDS: Health Biotechnology Hospitals Pharmaceutical Other Health

MEDIA:

Logo

Photo

Tom Pike has been named chief executive officer for Quintiles. He brings 30 years of experience spanning a variety of industries and leading companies. He spent 22 years at Accenture, including more than 10 years in leadership roles. (Photo: Business Wire)